The Latest Cardiac and Vascular News
HOUSTON–(BUSINESS WIRE)–Saranas Inc., a medical device company with innovative technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced that it has been granted de novo classification by the U.S. Food and Drug Administration (FDA) for the Early Bird Bleed Monitoring System. According to a recent […]
PASADENA, Calif, March 05, 2019 (GLOBE NEWSWIRE) — (via Blockchain Wire) ObEN Inc., the artificial intelligence (AI) company creating Personal AI (PAI) technology to revolutionize digital interactions, is pleased to announce it is working with MedStar Health Research Institute for a study on the use of Personal AI (PAI) healthcare assistants […]
Mountain View, Calif., March 5, 2019 /PRNewswire/ — Kinetic River Corp., a leader in custom flow cytometry instrumentation, announced today that it has been selected by the University of California, Davis, as a subcontractor on a National Science Foundation research grant. Prof. James Chan, the Principal Investigator on the NSF grant, is leading the […]
VANCOUVER, March 4, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that its Tiara™ (“Tiara”) transcatheter mitral valve replacement device […]
TEL AVIV, Israel, March 5, 2019 /PRNewswire/ — Vascular Graft Solutions Ltd. (VGS) announces the completion of patient enrollment in the company’s US Investigational Device Exemption (IDE) randomized, controlled pivotal study, evaluating the efficacy of the VEST external support for saphenous vein grafts in coronary artery bypass (CABG) surgery. The study enrolled 224 […]
KALAMAZOO, Mich., March 5, 2019 /PRNewswire/ — Innovative Cardiovascular Solutions, LLC (ICS), a privately held medical device company, today announced the first clinical use of its next-generation Emblok™ Embolic Protection System in patients undergoing transcatheter aortic valve replacement (TAVR) procedures in its European feasibility study. The cases were successfully performed by primary investigator […]
HINGHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) — Further expanding its global IP portfolio, Microbot Medical Inc. (Nasdaq CM: MBOT) received an official communication from the European Patent Office regarding its intention to grant European Patent Application No. 13 746 563, which covers an adjustable guidewire for use in percutaneous […]
SOUTH SAN FRANCISCO, Calif., March 04, 2019 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of serious cardiovascular diseases, today announced positive 12- and 24-week safety, efficacy and biomarker data for its investigational drug, mavacamten, from the company’s PIONEER […]
DANVILLE, Pa., March 4, 2019 /PRNewswire/ — The National Institutes of Health has awarded researchers at Geisinger $3.1 million over the next five years to explore innovative approaches for early, genomics-based detection of arrhythmogenic right ventricular cardiomyopathy (ARVC). ARVC is a degenerative heart disease responsible for approximately 20 percent of sudden cardiac death in individuals […]
SAN RAMON, Calif., Feb. 28, 2019 /PRNewswire/ — BioVentrix, Inc., a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced a significant reimbursement achievement. InEk, the German Institute for Hospital Remuneration, has reconfirmed the award of NUB Status 1 for the Revivent TC™ TransCatheter Ventricular Enhancement System. […]
